
%201.png)
Manufactured in a Controlled,
FDA-Registered Laboratory Environment
%202.png)


Scientific Leadership Driving Product Excellence
Dr. Haven McCall, PhD, provides scientific leadership in the development and manufacturing approach behind Luvacyt™ biologic products. His background in cellular science and regenerative technologies guides the company’s focus on standardized processing, quality control, and product consistency.
By integrating scientific expertise with controlled laboratory practices, Luvacyt maintains a commitment to producing biologic products designed to meet the needs of healthcare providers.
Dr. Haven McCall
Product Quality and Manufacturing Standards
Luvacyt™ biologic products begin with carefully selected donor tissue and are manufactured using standardized processing protocols designed to support consistency, purity, and viability. Strict quality controls are maintained throughout sourcing, processing, and final formulation to provide providers with biologic products they can trust.
Consistent Product Quality
Standardized protocols guide every stage of manufacturing—from donor tissue processing and cell isolation to purification and final formulation—supporting consistency and reproducibility across production batches. Each batch undergoes rigorous third-party quality testing, including viability and sterility evaluation, prior to release for distribution. A batch-specific Certificate of Analysis (COA) accompanies each product shipment to provide documented quality metrics and verification.
Comprehensive Donor Screening
Donor tissue is obtained from qualified sources and evaluated through comprehensive medical history review, serological testing, and risk assessment. Defined eligibility criteria and quality controls are applied prior to processing to support safety, traceability, and product integrity. Donor eligibility determinations include review of documentation by the laboratory’s Medical Director prior to acceptance for processing.
Controlled Manufacturing & Traceability
Manufacturing is performed in a controlled laboratory environment utilizing ISO-classified cleanroom conditions and established Quality Management Systems. From donor procurement through final formulation, comprehensive donor-to-vial traceability is maintained to support documentation integrity and product accountability. Standardized procedures aligned with Good Laboratory Practice (GLP) principles and environmental controls support consistent processing, product safety, and handling integrity throughout production.

Advanced Regenerative Biologic Products for Clinical Use
Luvacyt™ offers a portfolio of regenerative biologic products developed to support a wide range of clinical applications. Our product platform includes mesenchymal cell–based formulations, exosome products, and tissue-derived biologics manufactured using standardized processes designed to promote consistency and product integrity.
Each product is produced with an emphasis on quality, handling reliability, and documented performance metrics, supporting healthcare providers in delivering biologic-based therapies with confidence
Wharton’s Jelly Products
Tissue-Derived Biologics
Exosome Products
Mesenchymal Cell Products
Quality You Can Measure.
Consistency You Can Trust.
Luvacyt™ biologic products are manufactured using proprietary processing protocols developed and refined over more than two decades of laboratory experience in cellular science and regenerative technologies. These standardized methods are designed to support consistency, reproducibility, and product integrity across production batches.
Regulatory compliance and quality assurance are central priorities throughout manufacturing. Controlled laboratory processes, documentation standards, and environmental controls are maintained to support product safety, traceability, and handling integrity from production through distribution.
What Other Doctors Are Saying
"I was able to offer my patients something they'd never considered but felt safe and brought immediate results."
Dr. Pepper
"I was able to offer my patients something they'd never considered but felt safe and brought immediate results."
Dr. Dre
"I was able to offer my patients something they'd never considered but felt safe and brought immediate results."
Dr. Disrespect

.png)

